NEUP FDA Compliance Streak
Resolves: Successful completion of the next two annual FDA inspections without major non-compliance findings.
sec_filing· Regulatory Compliance
NEUP FDA Compliance Streak
Market overview
Derived from Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070) 10-Q filing analysis
Regulatory Compliance prediction market
- Implied probability (Yes)
- 85%
- Closes
- 2027-02-17
About this prediction
Resolution criteria
Successful completion of the next two annual FDA inspections without major non-compliance findings.
More Regulatory Compliance markets
- Absence of New Regulatory Actions — 90% Yes
- CMI Regulatory Compliance Outlook — 95% Yes
- Sustained Regulatory Compliance and Financial Reporting Integrity — 95% Yes
- FirstEnergy Ohio PIRB Trust: Regulatory Compliance Outlook — 95% Yes
- Absence of Regulatory Penalties — 95% Yes
- Exeter Automobile Receivables Trust 2027-3 Compliance with Servicing Criteria — 95% Yes
- Regulatory Compliance Assurance — 90% Yes
- Unqualified Auditor Opinion for 2026 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…